EDAP TMS reported EUR37.51M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
AngioDynamics USD 71.96M 3.68M Sep/2025
Boston Scientific USD 5.98B 446M Sep/2026
EDAP TMS EUR 37.51M 6.1M Mar/2026
Henry Schein USD 3.6B 110M Sep/2026
Medtronic USD 11.8B 141M Jun/2026
Plus Therapeutics USD 8.57M 612K Jun/2026
Veracyte USD 84.21M 21.47M Sep/2026